RK

Ratnakumari Kamepalli

Active Director Managing Director DIN 09353320
DIN 09353320 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ratnakumari Kamepalli

Data last updated:

Ratnakumari Kamepalli is a Managing Director at Medproven Pharma Private Limited (since 2021). The company operates in Chemicals.

DIN 09353320
Primary Designation Managing Director
Industry Chemicals
First Appointment 08 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medproven Pharma Private Limited U24290AP2021PTC119680
Managing Director08 Oct 20212021Active

Board colleagues of Ratnakumari Kamepalli

NameDINCompanyDesignation
Tirumalaprasadkamepalli09353321Medproven Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medproven Pharma Private Limited
Premium access

Shareholding and investment profile for Ratnakumari Kamepalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ratnakumari Kamepalli

Ratnakumari Kamepalli currently holds 1 directorship: Medproven Pharma Private Limited (Managing Director, since 08 Oct 2021).

Ratnakumari Kamepalli was first appointed on 08 Oct 2021 as Managing Director at Medproven Pharma Private Limited.

The current boards of Ratnakumari Kamepalli's companies include Tirumalaprasadkamepalli (Medproven Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available